Glatiramer Acetate Patent Expiration
Glatiramer Acetate is Used for treating multiple sclerosis. It was first introduced by Teva Pharmaceuticals Usa
Glatiramer Acetate Patents
Given below is the list of patents protecting Glatiramer Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Copaxone | US8232250 | Low frequency glatiramer acetate therapy | Aug 19, 2030 | Teva Pharms Usa |
| Copaxone | US8399413 | Low frequency glatiramer acetate therapy | Aug 19, 2030 | Teva Pharms Usa |
| Copaxone | US8969302 | Low frequency glatiramer acetate therapy | Aug 19, 2030 | Teva Pharms Usa |
| Copaxone | US9155776 | Low frequency glatiramer acetate therapy | Aug 19, 2030 | Teva Pharms Usa |
| Copaxone | US9402874 | Low frequency glatiramer acetate therapy | Aug 19, 2030 | Teva Pharms Usa |
| Copaxone | US5981589 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6054430 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6054430 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6342476 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6362161 | Copolymer-1 improvements on compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6362161 | Copolymer-1 improvements on compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6620847 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US6939539 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US7199098 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US7199098 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US8367605 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
| Copaxone | US8367605 | Copolymer-1 improvements in compositions of copolymers |
May 24, 2014
(Expired) | Teva Pharms Usa |
Glatiramer Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List